Structural Defects
Learn about birth defects caused by structural defects and tests offered by the Massachusetts General Hospital Department of Obstetrics & Gynecology used to identify them.
Patient Education5 Minute ReadDec | 15 | 2017
Prenatal diagnosis means finding birth defects during pregnancy. There are three different kinds of birth defects, including chromosomal disorders, and different tests to identify them. This information, along with consultation with your health care provider, will help you choose which tests you want. Most likely all of the results will be normal, and you will be reassured.
The blueprint of the body is ‘written’ in DNA, and the ‘words’ are called genes. These words are grouped together into chapters of varying length called chromosomes. We get one set of 23 chromosomes from each parent, for a total of 46. When a fetus doesn’t have the correct number of chromosomes, the most common result is a miscarriage. Sometimes the baby is born and can have problems after birth.
We need to examine a sample of fetal cells from the amniotic fluid or the placenta. There are two ways to obtain fetal cells.
Amniocentesis (sometimes called amnio) is most often done between 15 and 20 weeks. We insert a needle into the uterus and withdraw a small amount of the fluid that surrounds the baby. The risk that an amniocentesis could cause a miscarriage is so small that it’s hard to measure; we think it is about 2 in 1000, or 0.2 percent. It takes about 2 weeks to get the results.
CVS stands for chorionic villus sampling. We take a sample of the placenta typically between 10.5 and 14 weeks, so we can get the results earlier than from an amnio. However, it may be a bit more likely than amnio to cause a miscarriage. We think this happens in up to 10 in 1000 cases, or 1 percent.
Due to the risk of miscarriage, most often only women who have an increased risk of having an affected baby choose to have a CVS or amnio. These women are at increased risk:
The risk of chromosomal abnormalities gradually increases as a woman gets older, but there is nothing “special” about 35 year olds. For the same reason there is no simple way to separate a “worrisome” from a “reassuring” screening test result.
We use ultrasound and blood tests from the mother, along with the mother’s age, to estimate the risk of certain chromosome disorders, including Down syndrome. This can help women decide if they want to have an amnio or a CVS.
For example, a 39 year old woman starts out with a risk of Down syndrome of 10 in 1,000 (1%). Based on the results of a screening test we might make the risk higher, to perhaps 100 in 1,000 (10%); or we might make the risk lower, to perhaps 1 in 1,000 (0.1%). The first woman may decide to have an amnio or a CVS, while the second woman may be reassured by the lower risk and choose to avoid a procedure.
ERA, or Early Risk Assessment is performed between 11.5 and 14 weeks. We perform an ultrasound of the fetus and a maternal blood test. This allows us to calculate a risk for Down syndrome, trisomy 13 and trisomy 18.
If a woman is too far along for ERA, we can do a quad screen between 15 and 22 weeks. This is a maternal blood test that gives results that are similar to those obtained from ERA.
Cell Free DNA is also a blood test done on the mother. This test is better than ERA at detecting Down syndrome and trisomy 18, but may not be as good at detecting other chromosomal abnormalities. Neither ERA nor cell free DNA is as good as CVS or amnio, because only these invasive tests can reliably detect a wide range of chromosomal abnormalities without the need for additional confirmation.
As of 2015, most insurance policies will cover cell free DNA only for women who are at increased risk for a chromosomal abnormality based on age, family history, ERA, or findings on ultrasound. Low risk women who want this test will have to pay an additional charge.
We think that cell free DNA should be done in addition to, rather than instead of, an 11 - 14 week ultrasound.
Screening is not definitive. Although it can tell us that your risk of Down syndrome or trisomy 18 is low, even a very low risk is not the same as no risk at all. In addition, screening does not find other chromosomal abnormalities that can be only be detected by CVS or amnio.
Some people want to know if the result of a screening test is “good” or “bad.” It’s a lot more complicated than that, because there is no good way to separate “worrisome” from “reassuring” screening test results. We leave it up to the prospective parents to decide if they want more testing based on their individual risks and preferences.
All major insurance companies cover ERA or a quad screen. Also, all major insurance companies cover CVS and amniocentesis, but only for patients who are at high risk based on age, screening results, or other factors. They will not cover these procedures on patients who are low risk.
Coverage for cell free DNA varies greatly and there may be considerable out-of-pocket costs, particularly for low risk patients (younger than 35 without worrisome results from ultrasound or another screening test). If you are considering cell free DNA, we will help you determine your out-of-pocket cost.
No. Many women choose not to have any testing for chromosomal disorders.
Before you agree to have a test, you should think about what you will do with the information. Many couples would not have a CVS or amniocentesis under any circumstances. They would not end the pregnancy if the baby is affected, and/or they do not accept the risk of miscarriage from CVS or amnio. These couples might not want to have screening tests.
Think about these questions before deciding to have any form of genetic testing:
Remember that all of these tests are optional and entirely your choice. Discuss your options with your provider or a genetic counselor.
We offer state-of-the-art ultrasound and prenatal diagnostic testing and care to give you a clear picture of your baby’s health before birth.
We provide state-of-the-art, individualized care for women and their families before, during and after childbirth.
Our multidisciplinary team is renowned for its clinical excellence in diagnosing, treating and supporting patients with infertility issues.
The Department of Obstetrics and Gynecology at Mass General has advanced the science and the quality of care for patients since 1891.
Learn about birth defects caused by structural defects and tests offered by the Massachusetts General Hospital Department of Obstetrics & Gynecology used to identify them.
Learn about birth defects caused by genetic syndromes and tests offered by the Massachusetts General Hospital Department of Obstetrics & Gynecology used to identify them.
Find information about prenatal screening tests offered by the Department of Obstetrics & Gynecology at Massachusetts General Hospital.
The Department of Obstetrics & Gynecology at Mass General consistently ranks among the best women's health care providers in the country, offering innovative treatments from leading experts in obstetrics, gynecology, infertility, cancer, and urogynecology. Learn more about our department.